Top Markets
#1 Akedo Akedo +73.50%
#2 MEET48 MEET48 +26.11%
#3 Bitway Bitway +21.76%
#4 VeThor VeThor +21.08%
#5 Power Protocol Power Protocol +17.38%
#6 Tutorial Tutorial +16.23%
#7 Astar Astar +14.86%
#8 龙虾 (Lobster) 龙虾 (Lobster) +12.72%
#9 Falcon Finance Falcon Finance +12.11%
#10 Arbitrum Arbitrum +12.09%
Coin of the day
Akedo Akedo
설정
언어
한국어
통화
USD
테마
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
주식 순위 #37014
Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating... Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating therapies for the acute phase of thrombotic conditions. The company's lead compound, glenzocimab, is a humanized monoclonal antibody fragment specifically designed to target a particular platelet glycoprotein. Currently, Acticor Biotech is advancing two clinical programs, both in Phase II/III, for the registration of treatments for ischemic stroke. Additionally, it is conducting two other Phase II trials concerning significant cardiovascular emergencies, with anticipated clinical data expected from both its ischemic stroke research and studies related to COVID-19 respiratory distress syndrome. Established in 2013, the company operates from its headquarters in Paris, France.
주가
$0.25974701
마지막 동기화: 2025-01-06
시가총액
$2.04M
변동 (1일)
0.74%
변동 (1년)
0.00%
국가
FR
거래 Acticor Biotech SAS (ALACT)

카테고리

Healthcare
Acticor Biotech SAS (ALACT)의 주식 분할 이력
Acticor Biotech SAS 주식 (심볼: ALACT)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Sep 15, 2026에 발생했습니다.
Sep 15, 2026 이전에 매수한 ALACT 주식 1주는 현재 0주의 ALACT 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH